Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pasithea Therapeutics Corp.

1.69
-0.0400-2.31%
Post-market: 1.67-0.0183-1.08%16:01 EDT
Volume:180.77K
Turnover:314.17K
Market Cap:4.57M
PE:-0.13
High:1.80
Open:1.71
Low:1.55
Close:1.73
Loading ...
Jun 01, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 03, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2021

Major Issues Report

8-K - Current report
Dec 20, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 09, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 29, 2021

Major Issues Report

8-K - Current report
Nov 18, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 22, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 13, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 10, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 27, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses